(Reuters) – U.S. regulators granted Pfizer Inc a reissued patent on its multibillion-dollar Celebrex pain drug that extends its marketing exclusivity until early December 2015, the company said on ...

While this was generally a known event coming down the pipe, Celebrex now has a generic competitor in America. The drug company Actavis PLC (NYSE: ACT) announced on Wednesday that it has launched a ...

Q. I have been using Celebrex for osteoarthritis, and it has worked well for me for many years. The pharmacy substituted generic celecoxib. After only four days, I am in a lot of pain, especially in ...

Pharmaceutical giant Pfizer said on Wednesday it will appeal a US federal court's refusal to extend patent protection for its blockbuster Celebrex drug used to treat arthritis. Pfizer said the US ...

NEW YORK (Reuters) - Pfizer Inc. said on Monday the Federal Court of Appeal of Canada has blocked generic drugmaker Teva Pharmaceutical Industries Ltd. from launching a copycat form of its Celebrex ...

A federal appeals court reversed a Food and Drug Administration ruling that effectively blocked until June Mylan Pharmaceuticals Inc., Watson Laboratories Inc. and Lupin Pharmaceuticals Inc. from ...

Back in 2004, a popular arthritis drug called Vioxx was pulled off the market when studies showed daily long-term use could increase the risk of heart attack, stroke and death. “This was one of the ...

NEW ORLEANS – Pfizer Inc's Celebrex arthritis drug was shown to be at least as safe as the widely used prescription-strength versions of painkillers ibuprofen and naproxen, and does not appear to ...

The US Food and Drug Administration (FDA) today approved the first generic versions of the anti-inflammatory drug celecoxib (Celebrex, Pfizer) in the wake of legal wrangling between the brand-name ...

NEW YORK, April 30 (Reuters) - Pfizer Inc. said on Monday the Federal Court of Appeal of Canada has blocked generic drugmaker Teva Pharmaceutical Industries Ltd. from launching a copycat form of its ...